Application 215464
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IBRUTINIB | IBRUTINIB | TABLET;ORAL | 140MG | No | No |
| 002 | IBRUTINIB | IBRUTINIB | TABLET;ORAL | 280MG | No | No |
| 003 | IBRUTINIB | IBRUTINIB | TABLET;ORAL | 420MG | No | No |
| 004 | IBRUTINIB | IBRUTINIB | TABLET;ORAL | 560MG | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Imbruvica | IBRUTINIB | Pharmacyclics LLC | 0dfd0279-ff17-4ea9-89be-9803c71bab44 | 2025-10-21 | Warnings, Adverse reactions | IBRUTINIB |